Literature DB >> 7001860

Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin.

M Gutniak, U Rosenqvist, L Grimelius, J M Lundberg, T Hökfelt, A Rökaeus, S Rosell, G Lundqvist, J Fahrenkrug, R Sundblad, E Gutniak.   

Abstract

A patient with water diarrhoea syndrome (WDS) is described. A pancreatic tumour was found containing many cells with immunoreactivity to enkephalin and neurotensin, a few with immunoreactivity to calcitonin but none to vasoactive intestinal peptide (VIP). High levels of calcitonin, neurotensin, VIP and pancreatic polypeptide (PP) were present in plasma as measured by radioimmunoassay. After removal of the tumour, the plasma levels of the first three peptides returned to normal and the WDS disappeared. On the other hand, plasma PP did not change. No specific symptoms could be attributed to the new spectrum of peptides found in the tumour. This is the first report of a pancreatic tumour containing high levels of neurotensin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7001860     DOI: 10.1111/j.0954-6820.1980.tb01159.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  9 in total

1.  Calcitonin-secreting VIPoma.

Authors:  Christian Jackson; Alan L Buchman
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  Pancreatic endocrine tumours associated with WDHA syndrome. An immunohistochemical and electron microscopic study.

Authors:  A Ooi; T Kameya; M Tsumuraya; K Yamaguchi; K Abe; Y Shimosato; N Yanaihara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

3.  Histamine release from isolated rat mast cells by neurotensin and other peptides.

Authors:  A Sydbom
Journal:  Agents Actions       Date:  1982-04

Review 4.  Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature.

Authors:  Silvia Uccella; Annika Blank; Roberta Maragliano; Fausto Sessa; Aurel Perren; Stefano La Rosa
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

5.  Two patients with pancreatic apudomas secreting neurotensin and VIP.

Authors:  S R Bloom; Y C Lee; J M Lacroute; A Abbass; D Sondag; R Baumann; J P Weill
Journal:  Gut       Date:  1983-05       Impact factor: 23.059

6.  Neurotensin-secreting carcinoma of the bronchus.

Authors:  J R Wood; S M Wood; Y C Lee; S R Bloom
Journal:  Postgrad Med J       Date:  1983-01       Impact factor: 2.401

7.  A calcitonin and vasoactive intestinal peptide-producing pancreatic endocrine tumor associated with the WDHA syndrome.

Authors:  Tatsunosuke Ichimura; Satoshi Kondo; Shunichi Okushiba; Toshiaki Morikawa; Hiroyuki Katoh
Journal:  Int J Gastrointest Cancer       Date:  2003

8.  [Neurotensin--what is known about its role as a hormone in the gastrointestinal tract?].

Authors:  V E Eysselein
Journal:  Klin Wochenschr       Date:  1984-06-01

9.  Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy.

Authors:  Zherui Wu; Daniel Martinez-Fong; Jean Trédaniel; Patricia Forgez
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-17       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.